Results for "Inexpensive medicines https://simplemedrx.top"
HDA Factbook: Rx Sales Through Traditional Healthcare Distributors Increase
New data released by the HDA Research Foundation reveal that total prescription sales through traditional pharmaceutical distribution jumped 15.5 percent in 2022 to reach $666 billion. As highlighted in the 94th Edition HDA Factbook, an estimated 95 percent of all pharmaceutical sales move through the traditional distribution channel. Moreover, distributors are operating on the lowest margins in the study’s history — in 2022, the industry’s net profit margin after taxes was 0.4 percent.
Distributors Leading the Way in the Next Phase of COVID-19
Since the emergence of COVID-19, HDA distributor members have worked tirelessly to navigate the exceptional and unprecedented demands of this public health emergency. From managing unique inventory demands of the first hotspots, to ensuring access to emerging treatment options and testing, HDA members draw upon their extensive supply and distribution networks, logistics expertise and experience navigating public health emergencies. Moreover, distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery and improving pandemic resiliency for the future.
Less Than a Year From the DSCSA Deadline, Experts Discuss the Road to Compliance
The Drug Supply Chain Security Act (DSCSA) has entered its final year of implementation. For the past nine years, HDA has brought together supply chain partners, represented distributors’ insights and expertise with FDA and other regulators, and led educational initiatives aimed at informing and preparing supply chain stakeholders for 2023. At the October Traceability Seminar in Washington, D.C., HDA spoke with several industry experts, who were asked to share insights from across the DSCSA’s legislative and implementation process as part of our Faces of the Supply Chain series. Key highlights from these conversations are captured in this piece.
HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.
Read three takeaways from the conversation.
HDA Research Foundation Announces 2022–2023 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation today announced the four recipients of its graduate-level Karen J. Ribler Scholarship.